Health
Regeneron’s Antibody Combination Therapy Reduces COVID-19 Mortality Risk – BioPharm International
RECOVERY trial results have shown that Regeneron’s investigational antibody combination therapy reduces the mortality risk for…
Results of the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial have shown that Regenerons investigational antibody combination therapy reduces the mortality risk for hospitalized patients with severe COVID-19 whose immune response has not started…
Continue Reading
-
Noosa News20 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
Noosa News18 hours agoMissing man, Maroochydore – Queensland Police News
-
General22 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News9 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland